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Background: Caspases are a family of cysteine proteases that have important
intracellular roles in inflammation and apoptosis. Caspase-8 activates
downstream caspases which are unable to carry out autocatalytic processing
and activation. Caspase-8 is designated as an initiator caspase and is
believed to sit at the apex of the Fas- or TNF-mediated apoptotic cascade. In
view of this role, the enzyme is an attractive target for the design of inhibitors
aimed at blocking the undesirable cell death associated with a range of
degenerative disorders.
Results: The structure of recombinant human caspase-8, covalently modified
with the inhibitor acetyl-Ile-Glu-Thr-Asp-aldehyde, has been determined by X-ray
crystallography to 1.2 Å resolution. The asymmetric unit contains the p18–p11
heterodimer; the biologically important molecule contains two dimers. The
overall fold is very similar to that of caspase-1 and caspase-3, but significant
differences exist in the substrate-binding region. The structure answers
questions about the enzyme–inhibitor complex that could not be explained from
earlier caspase structures solved at lower resolution. 
Conclusions: The catalytic triad in caspase-8 comprises Cys360, His317
and the backbone carbonyl oxygen atom of Arg258, which points towards
the Nε atom of His317. The oxygen atom attached to the tetrahedral carbon
in the thiohemiacetal group of the inhibitor is hydrogen bonded to Nδ of
His317, and is not in a region characteristic of a classical ‘oxyanion hole’.
The N-acetyl group of the inhibitor is in the trans configuration. The 
caspase-8–inhibitor structure provides the basis for understanding
structure/function relationships in this important initiator of the proteolytic
cascade that leads to programmed cell death. 
Introduction
The caspases are a family of related cysteine proteases
that have important intracellular roles in inflammation and
apoptosis (see [1–8] for reviews and further references).
Members of this protease family, which currently number
more than a dozen, share various features in common, but
are structurally unrelated to the papain superfamily of cys-
teine proteases. They all employ a conserved cysteine
residue as the nucleophile for attack on peptide bonds,
and the sites of cleavage all contain aspartate in the P1
position of the peptide substrates [9,10]. The caspase cat-
alytic domain has a mass of ~30 kDa and comprises two
polypeptide chains: a 17–20 kDa N-terminal fragment
(α subunit), which contains the active-site cysteine, and a
10–12 kDa C-terminal fragment (β subunit) which con-
tributes to the formation of the active site. These chains
arise by internal cleavage of a single-chain zymogen pre-
cursor, and are tightly associated in an αβ heterodimer.
Proteolytic processing which gives rise to these compo-
nent polypeptides is either autocatalytic or is mediated
by other caspases or enzymes of similar specificity
(e.g. granzyme B). The αβ dimeric protein associates
further to form an α2β2 heterotetramer that appears to be
required for catalytic activity. Three-dimensional struc-
tures of enzyme–ligand complexes have been reported for
both caspase-1 (interleukin-converting enzyme; ICE)
[11,12] and caspase-3 (CPP32, also known as apopain or
Yama) [13,14] from 2.3–2.5 Å resolution.
As with all proteolytic enzymes, the caspases exist as inac-
tive precursors or proenzymes. The length of the N-termi-
nal prodomains of the caspases varies considerably
depending on how activation is regulated. Our interest has
been focused on those caspases which are involved in
apoptosis, principally caspase-8 and one of its natural sub-
strates, caspase-3 [15]. The catalytic regions of caspase-3
and caspase-8 correspond closely with regard to length,
placement of the active-site cysteine, and the pattern of
processing required for activation. The remarkable dis-
tinction between the two is in the greater length of the
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N-terminal prodomain in caspase-8, a region that contains
two death-effector domains (DEDs). Immunoprecipita-
tion experiments of activated death-initiation signaling
complexes (DISCs) show that procaspase-8 is a compo-
nent of the activated receptor complex [16]. Because of
sequence homology between the DEDs of procaspase-8
and the death domains (DDs) of FADD and TRADD, the
death domain proteins associated with Fas and tumor
necrosis factor (TNF) receptors [17], the DEDs are
thought to result in association or recruitment of procas-
pase-8 to the activated receptors. Therefore, as a compo-
nent of activated DISC, procaspase-8 is positioned in the
direct line of signal transduction induced by a variety of
effectors such as TNF-α. Activation of the Fas or TNF
receptors with Fas ligand or TNF-α results in the autocat-
alytic activation of procaspase-8 [18]. Activated caspase-8
is then thought to activate other downstream caspases,
like caspase-3, which have shorter prosegments with intra-
cellular concentrations that are not high enough to support
their autocatalytic processing and activation. Thus,
caspase-8 has been designated as an ‘upstream’ caspase
and is believed to sit at the apex of the Fas- or TNF-
mediated apoptotic cascade. The likely role of caspase-8 is
to serve as the prime mover for activation of downstream
caspases such as caspase-3, the ‘executioners’ of apoptosis;
the function of these downstream caspases is to destroy
critical cellular proteins in programmed cell death [1]. 
Because of its initiating role in Fas- or TNF-mediated
apoptosis, caspase-8 is a likely target in blockade of the
undesirable cell death which occurs in a variety of diseases
[19–21]. Drugs that will selectively inhibit this activity
could well find important therapeutic application, and one
avenue towards drug design is via a well-defined three-
dimensional structure of an enzyme–inhibitor complex. In
the present paper, we report the structure of recombinant
human caspase-8 at atomic resolution (1.2 Å). The high
quality of this structure serves as an important basis for
evaluating detailed interactions between ligands and the
enzyme subsites, and for the development of inhibitors
with optimized binding properties. In addition, the nature
of the catalytic region is more clearly elucidated in the
current study due to the high resolution. 
Results and discussion
The caspase-8 structure is the third caspase structure to
be solved crystallographically and may now be compared
to those of caspase-1, an enzyme associated with inflam-
mation, and caspase-3, the downstream executioner of
apoptosis. Armed with the caspase-8 structure, it is possi-
ble to compare spatially equivalent amino acid residues in
the three caspases and to note similarities and differences
that help explain their specific functions. Moreover, the
high resolution of the caspase-8 structure has helped to
clarify some issues regarding the enzyme mechanism and
substrate binding.
In the present caspase literature, the numbering of amino
acid residues is often based upon their positions in the
proenzymes, and as the proenzymes differ dramatically in
the lengths of their prosegments this leads to differences
in numbering of residues in the catalytic domains
(Figure 1; see Cohen [2]). Throughout this paper, in our
comparisons of structurally equivalent amino acids in the
three caspases, we will follow this convention of number-
ing residues according to their position in the correspond-
ing proenzymes. The two subunits of caspase-8 will be
referred to as the p18 and p11 subunits.
Production of recombinant human caspase-8
The protein sequence of the procaspase-8 construct
employed in this work is given in Figure 1, and the align-
ment and identification of spatially equivalent residues in
caspase-3 and caspase-1 are also presented for comparison.
The protein, expressed as inclusion bodies in Escherichia
coli, was recovered by dissolution in 6 M guanidinium
chloride and then transferred to solution in 50% acetic
acid. Following dilutions in water, and finally into 1 M
Tris buffer (pH 8.0), the procaspase-8 remained in dilute
solution. Concentration of this solution by ultrafiltration
led to autoprocessing of the proenzyme to highly active
caspase-8. Details with regard to this procedure will be
published elsewhere. Sequence and mass spectrometric
analysis of the activated caspase-8 (data not shown) estab-
lished that the p18 subunit begins at Ser211 and extends
to Asp374; the p11 subunit starts at Leu385 and continues
to the C-terminal Asp479 (Figure 1). Our autocatalytically
processed caspase-8 preparations readily cleaved the
chromogenic caspase-8 (acetyl-Ile-Glu-Thr-Asp-para-
nitroaniline; Ac-IETD-pNA) or caspase-3 (Ac-DEVD-
pNA) substrates, but exhibited no measurable activity
toward the caspase-1 substrate Ac-YVAD-AMC (where
AMC is 7-amino-4-methylcoumarin). For the optimal sub-
strate, Ac-IETD-pNA, the Km value was measured as
66 ± 5 µM and Vmax was 8.43 ± 0.18 µmol/min/mg. Protein
modified with the peptidic inhibitor Ac-IETD-aldehyde,
a substrate mimic which covalently modifies the active-
site Cys360 (IC50 = 50 nM), was crystallized and deter-
mined by X-ray crystallography. 
The overall structure of caspase-8
The heterodimer
The asymmetric unit contains the p18–p11 heterodimer
(Figure 2). The overall topology is similar to that of
caspase-1 and caspase-3, with the p18 and p11 subunits
folded into a compact cylinder of ~28 Å × 37 Å × 48 Å. The
protein has an α/β folding motif with a central six-stranded
β sheet with five parallel strands (β1, residues 231–241; β2,
278–285; β3, 308–316; β4, 351–358; β5, 397–404) and one
antiparallel strand (β6, residues 462–467). These structural
elements are defined for caspase-8 in Figure 1. The
β antiparallel strand lies on the edge of the β sheet, per-
pendicular and adjacent to the crystallographic twofold
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axis. Also identified in Figure 1 are the six α helices (α1′,
residues 244–250; α1, 261–276; α2, 289–302; α3, 332–341;
α4, 419–435; α5, 438–452). Three α helices are located on
one side of the main β sheet and two on the other side.
There is also a turn of helix (α1′) that is part of a large loop
(loop 1) that occurs along the binding-pocket region of the
p18 subunit. A two-stranded antiparallel β sheet made up
of contributions from loop 3 (residues 317–320) and loop 4
(residues 408–415) is found at the top of the main β sheet
and forms the base of the binding pocket. In the hetero-
tetramer, the first segment (residues 385–396) of the p11
subunit and the last segment (residues 363–374) of the p18
subunit extend from the compact structure in an antiparal-
lel fashion and interact across the crystallographic twofold
axis with the other heterodimer.
Many differences are observed among caspase-1, caspase-3
and caspase-8 in the loop regions near the active site;
these are indicated structurally in Figure 3 and in terms of
amino acid sequence in Figure 1. When compared to
caspase-3, caspase-8 has an insertion of seven residues,
designated as loop 1, between strand β1 and helix α1. In
comparison with caspase-1, this loop is even bigger (a ten-
residue insertion) and this larger sized loop in caspase-8 is
clearly seen in the structural overlay. This insertion
includes a helical segment, α1′, which has not been
observed in either caspase-1 or caspase-3. In caspase-1,
loop 3 is six residues longer than in caspase-3 and caspase-
8, again this is clearly evident in Figure 3. Loop 4 is iden-
tical in length in all three caspases, and this is seen in the
coincidence of fold in this region. Loop 5 is intermediate
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Figure 1
Amino acid sequence alignment of caspase-8,
caspase-3 and caspase-1. Spatially aligned
α helix and β sheet secondary structure
elements are indicated. Alignment of the ends
and loop (L) regions of the subunits is not
implied. The first 12 residues of p18 and the
first five residues of p11 are disordered.
in length between caspase-3 and caspase-8. All three cas-
pases adopt different conformations in this region and
these differences have an important bearing on the speci-
ficity of the S4 pocket. 
The heterotetramer and dimer–dimer interface
Two p18–p11 heterodimers form a tetramer around a crys-
tallographic twofold axis (Figure 3). This association
extends the six strands of the β sheet per dimer to
12 strands with the twofold axis perpendicular to the middle
of the β sheet. Besides the extended β sheet there are other
interactions around the twofold axis which influence the
substrate-binding region. Residues Lys367–Asp374 of one
heterodimer extend into the twofold-related molecule to
form interactions with residues Thr390–Asp395.
The crystal structures of caspase-1 in two crystal forms
and caspase-3 in two crystal forms show similar tetrameric
interactions to those found in caspase-8. Structural and
mutagenic studies indicate that this tetramer and the
dimer–dimer interface are necessary for biological activity.
The formation of the heterotetramer probably modifies
the neighboring tertiary structure resulting in the activa-
tion of the catalytic and substrate-binding site. The
approximate area of the solvent accessible interface
between the two dimers is 2100 Å2 in caspase-8. Both
hydrophobic and hydrophilic interactions are important in
forming a strong dimer–dimer interface. This interface
contains 23 hydrogen bonds (or 12 per dimer) with main-
chain and sidechain atoms involved (Table 1). A deep
cavity of 17 × 15 × 11 Å3 is present on the crystallographic
twofold axis (Figure 4a). This cavity is larger than those
observed in caspase-3 (Figure 4b) and caspase-1
(17 × 7 × 11 Å3 and 9 × 5 × 11 Å3, respectively [14]). There
is a clearly identifiable oxidized dithiothreitol molecule
(1,2-dithiane-4,5-diol; Figure 4c) and its symmetry-related
pair in this cavity. These dithiane-diol molecules are sepa-
rated by ~13 Å and are ~19 Å from the P1–P4 substrate-
binding pocket. Another dithiane-diol molecule is located
elsewhere on the surface of the protein. Examination of
other data sets indicate that these dithiane-diol molecules
are not always present in crystals of caspase-8, but depend
on the concentration of dithiothreitol in the buffer and the
age of the crystals. It is possible that ligand binding in the
central cavity could effect that catalytic activity of the
enzyme and further work is planned to study the effects of
ligand binding in the cavity.
Binding of the tetrapeptide inhibitor
Figure 5 shows a schematic of the hydrogen-bond interac-
tions of the inhibitor Ac-IETD-aldehyde with caspase-8.
Figure 6a shows the electrostatic surface of the protein
and the quality of the electron-density map for the
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Figure 2
Backbone ribbon diagram [36] of the caspase-8 heterodimer.
Secondary structure elements are labeled; the p18 subunit is shown in
yellow and the p11 subunit in green. The N and C termini of the
subunits are labeled. The Ac-IETD-thiohemiacetyl inhibitor is shown as
a ball-and-stick model.
Figure 3
Backbone drawing of the superimposed structures of caspase-8
(yellow), caspase-3 (green) and caspase-1 (cyan). The dyad-related
caspase-8 dimer is shown as a white cord. Loops of the protein
surrounding the substrate-binding pocket and the approximate location
of the binding subsites (S1–S4) are indicated. The orientation of the
figure is similar to that in Figure 2.
inhibitor bound to caspase-8. The inhibitor binds in an
extended conformation with the aldehyde forming a thio-
hemiacetal bond to Sγ of Cys360 (Figure 6b). In caspase-8,
the mainchain of the inhibitor, as in many other proteases
[22], is antiparallel with respect to residues lining the
binding pocket (residues 411–413). The P1–P3 residues
form a β-sheet type hydrogen-bonding network. The
active-site cysteine (Cys360) resides on a long C-terminal
segment of p18 (Figure 1) which interacts with the N-ter-
minal portion of the p11 subunit in the twofold-related
heterodimer (Figure 2). The acetyl end of the inhibitor is
situated near loop 4.
The active site and the S1 pocket
The carboxyl group of the P1 aspartate residue forms salt
bridges with Arg413 and Arg260 and hydrogen bonds to
Gln358 in a pattern similar to that found in caspase-1 and
caspase-3. All these residues are conserved. The P1 α-car-
bonyl group rotates and the oxygen atom rehybridizes
(sp2–sp3) to become a hydroxyl group and form a hydrogen
bond with the imidazole group of His317 (Figure 6b).
Mittl et al. [14] suggested that the ICE-like proteases have
a catalytic Cys/His dyad rather than the classical
Cys/His/Asn triad as found in papain and most other cys-
teine proteases. Wilson et al. [12] also proposed the
Cys/His catalytic dyad for caspase-1, but indicated the
possible involvement of a putative third component, the
backbone carbonyl oxygen of Pro177, that could affect the
basicity of the histidine imidazole. In fact, Rotonda et al.
[13] later invoked the existence of the same carbonyl
oxygen in caspase-3, this time from the spatially equiva-
lent Thr62 in an interaction with the catalytic imidazole
ring. No one has provided evidence that this backbone
carbonyl oxygen might have a role as the third member of
a catalytic triad. Based upon our high-resolution structure
of caspase-8, a clear interaction exists between the car-
bonyl oxygen of Arg258, equivalent to Pro177 in caspase-1
and Thr62 in caspase-3, and the Nε of His317. We infer,
therefore, that irrespective of the nature of the amino acid
at this position, the carbonyl oxygen can serve as a
member of a catalytic triad in the caspases.
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Table 1
Hydrogen-bond contacts between heterodimers along the
dimer–dimer interface.
Atom Residue Atom* Residue* Distance (Å)
Oδ1 D223 Nη1 R432 2.60
Nε2 N366 N E396 2.97
O K367 N D395 2.92
N I369 O I393 2.87
O I369 N I393 3.01
N V371 O R391 2.91
Oδ2 D374 Nζ K472 2.90
O Y392 Nζ K461 2.88
Oγ1 T441 Nζ K473 2.91
Oδ1 N447 O L470 2.83
O P466 N F468 3.01
Oγ1 T467 Oγ1 T467 2.90
Nη1 R432 Oδ1 D223 2.60
N E396 Nε2 N366 2.97
N D395 O K367 2.92
O I393 N I369 2.87
N I393 O I369 3.01
O R391 N V371 2.91
Nζ K472 Oδ2 D374 2.90
Nζ K461 O Y392 2.88
Nζ K473 Oγ1 T441 2.91
O L470 Oδ1 N447 2.83
N F468 O P466 3.01
*Denotes the symmetry-related molecule. Residues are given in single-
letter amino acid code.
Figure 4
Molecular surface representation of (a) caspase-8 and (b) caspase-3
generated using the program GRASP [37] and viewed down the
twofold axis. Areas of negative and positive electrostatic potential are
shown in red and blue, respectively. The surface is viewed
approximately parallel to the twofold axis. The central cavities are
outlined in black and the tetrapeptide inhibitors and dithiane-diol
molecules are shown as stick models. (c) Close-up view of the
electron density of the dithiane-diol molecule located in the central
cavity of caspase-8.
The tetrahedral nature of the thiohemiacetal carbon atom
is clearly evident in the 1.2 Å resolution map. This is the
same conformation as was modeled for the aldehyde
inhibitor-bound models of caspase-1 and caspase-3 [13],
but different from those modeled for the methylketone
inhibitors in which the carbonyl oxygen extends into the
‘oxyanion’ pocket. There was some uncertainty regarding
the different interpretation of the conformation in this
region, because the other caspase structures were deter-
mined with ~2.5 Å resolution data. Our data at high resolu-
tion clearly establishes the interaction between the
thiohemiacetal hydroxyl group and Nδ of His317. In the
case of the caspase-3–Ac-Asp-Val-Ala-Asp-fluoromethylke-
tone structure [14], the carbonyl oxygen points directly
into the presumptive ‘oxyanion hole’ to form a hydrogen
bond with a peptide NH group in a highly conserved
region of the enzyme (a glycine residue in caspases-8, -3
and -1 at residues 350, 122 and 238, respectively; Figure 1).
We would agree with earlier interpretations that the thio-
hemiacetal can, and in this case does, bind in a non-transi-
tion state conformation [23,24].
The S2 pocket
The Cγ atom of the threonine sidechain at P2 lies in a
hydrophobic pocket formed by the sidechains of Val410
and Tyr412 (Tyr204 and Trp206 in caspase-3). The Oγ
atom is surrounded by water molecules, one of which
forms a bridge to Oη of Tyr365. 
The S3 pocket
The glutamate at P3 sits in a cleft defined by Arg413,
Arg258, Pro415 and Asn261. All interactions with these
residues are mediated through solvent molecules with the
exception of that to Arg413. This residue forms salt bridges
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Figure 5
Hydrogen-bonding scheme in the
caspase-8–Ac-IETD-thiohemiacetyl complex.
The ligand is covalently linked to the active-
site nucleophilic Cys360 through a
thiohemiacetal bond. The hydrogen bonds
are represented by dashed lines. The binding






























































Electron densities of the catalytic and
inhibitor-binding regions. (a) Electron density
of the inhibitor and substrate-binding pocket
superimposed on the electrostatic surface of
the protein calculated using Amber
parameters [38]. The protein surface is color-
coded: red, negative; blue, positive; yellow,
slightly negative; white, neutral; and cyan,
slightly positive. (b) The electron density of
the catalytic triad region. Hydrogen bonds are
indicated by dashed lines.
to both the P3 glutamate and P1 aspartate sidechains.
Besides these salt bridges, Arg413 is a crucial residue
forming hydrogen-bond interactions between its main-
chain atoms and the mainchain of the peptide inhibitor. In
caspase-8, the preference for glutamate in the S3 pocket is
enhanced by the proximity of Arg258 and Asn261; for
example, Arg258 and Asn261 of caspase-8 correspond to
Thr62 and Ser65, respectively, in caspase-3. 
The S4 pocket
Comparing the specificities of the different caspases sug-
gests that the size and nature of the S4 pocket is especially
important in selectivity [25]. Caspase-3 prefers an aspar-
tate residue in the P4 position, whereas caspase-1 and
caspase-8 prefer hydrophobic groups. In caspase-8, the
acetyl of the inhibitor hydrogen bonds through a water
bridge to the carboxyl group of the P3 glutamate. The S4
pocket of caspase-8 differs from that of caspase-3, with the
hydrogen-bond participants moving away to be replaced
by nonpolar interactions. These new interactions are
chiefly formed with the faces of the aromatic groups of
Trp420 and Tyr412, with the Cγ1–Cδ atoms of the P4
isoleucine residue inserted between them. The Cγ2 atom
of isoleucine is in a fairly open region surrounded by water
molecules and additional functional groups might be sub-
stituted in this area.
Biological implications
The caspases are a family of related cysteine proteases
that have important intracellular roles in inflammation
and apoptosis, but are structurally unrelated to the
papain superfamily of cysteine proteases. Activated
caspase-8 (an α2β2 heterotetramer) activates other
downstream caspases that are incapable of autocatalytic
processing and activation. Thus, caspase-8 has been des-
ignated as an initiator caspase and is believed to sit at the
apex of the Fas- or TNF-mediated apoptotic cascade. 
The three-dimensional structure of recombinant human
caspase-8, covalently modified with the inhibitor acetyl-
Ile-Glu-Thr-Asp-aldehyde, has been determined by
X-ray crystallography to a resolution of 1.2 Å. The
asymmetric unit contains the p18–p11 heterodimer; the
biologically important molecule consists of two twofold
related heterodimers which form a tetramer. The dimer
has a typical α/β folding motif with a central six-stranded
β sheet made up of five parallel strands and one antipar-
allel strand. There are five α helices in the core, three on
one side of the main β sheet and two on the other side.
A two-stranded, antiparallel β sheet that is part of the
binding pocket is present at the top of the main β sheet.
Not unexpectedly, the core protein fold is very similar to
that of caspase-1 and caspase-3, but significant differ-
ences are seen in the substrate-binding region. This
structure, at near atomic resolution, has helped answer
some questions about the enzyme–inhibitor complex that
could not be clearly explained from the earlier caspase
structures solved at lower resolution. 
Caspase-8 contains a catalytic triad consisting of Cys360,
His317 and the backbone carbonyl oxygen atom of
Arg258, which points towards the Nε atom of His317.
The utilization of a backbone carbonyl atom in the triad
is unusual, as most cysteine proteases employ the car-
bonyl of a sidechain. The oxygen atom attached to the
tetrahedral carbon in the thiohemiacetal group of the
inhibitor is in close association, and most likely hydrogen
bonded, with the Nδ atom of His317 and is not in a
region characteristic of a classical ‘oxyanion hole’.
The N-acetyl group of the inhibitor is clearly seen in the
trans configuration. The S4 pocket differs from that of
caspase-3 with the hydrogen-bond participants moving
away to accommodate a nonpolar residue. The faces of
the aromatic residues Trp420 and Tyr412 help to form
part of this hydrophobic S4 pocket. 
The caspase-8–inhibitor interactions defined at this high
level of resolution provide the basis for understanding
structure/function relationships in this important initia-
tor of the proteolytic cascade that ultimately leads to pro-
grammed cell death. 
Materials and methods
Gene construction and protein expression
The gene for the procaspase-8 construct was cloned into the Bam HI
and Hind III sites of vector pQE30 (Qiagen) and transformed into M15
(pREP4) cells (Qiagen) for propagation and expression in E. coli, using
standard protocols. Cell cultures were grown in luria broth (LB) with
100 µg/ml ampicillin and 25 µg/ml kanamycin. At A550 = 0.7–0.8,
expression was induced by the addition of 1 mM isopropyl-β-D-thio-
galactopyranoside (IPTG). Cells were harvested after 30 min, resus-
pended in 10 mM Tris (pH 8.0) 1 mM EDTA and frozen at –70°C. The
presence of inclusion bodies was determined by light microscopy.
Cells were disrupted by sonication and the inclusion bodies were sep-
arated from soluble proteins and cell debris by low-speed centrifuga-
tion (Sorvall SS34, 3000 rpm, 30 min).
Refolding protocol
E. coli inclusion bodies harboring the procaspase-8 were resuspended
in 10 mM Tris buffer (pH 8.0) containing 1 mM EDTA, washed in the
same buffer, and finally collected by centrifugation at 1074 × g. The
inclusion bodies were then dissolved in 6 M guanidinium chloride,
0.1 M Tris (pH 8.0) containing 5 mM dithiothreitol (DTT), and insoluble
material was removed by centrifugation.
The solution of procaspase-8 in 6 M guanidinium chloride (2–3 mg
protein/ml) was treated with an equal volume of glacial acetic acid fol-
lowed by dialysis against 50% acetic acid. This solution was added
rapidly to nine volumes of water to produce a clear solution of protein
in 5% acetic acid. The pH was brought rapidly to 8 by addition of this
solution to nine volumes of 1.0 M Tris buffer (pH 8) containing 5 mM
DTT. This resulted in a clear solution of procaspase-8 at neutral pH.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS–PAGE) showed a single band corresponding to a mass of
33 kDa (data not shown).
The solution of protein was concentrated by ultrafiltration in an Amicon
stirred cell concentrator. This concentration step led to conversion of
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all of the 33 kDa procaspase-8 to the p20 and p10 species that are
characteristic of the activated caspase. 
Analytical methods
Protein quantitation was afforded by amino acid analysis employing a
Beckman Model 6300 ion-exchange instrument. Protein sequencing
was performed using a Perkin Elmer/Applied Biosystems ProciseTM
Sequencer. The masses of major procaspase processing fragments
and intermediates were determined with electrospray ionization on a
Micromass Quattro II MS and MALDI ionization on a Perseptive Biosys-
tems Voyager Elite time-of-flight MS. SDS–PAGE was carried out using
Novex 16% Tris-glycine or 10% NuPage Bis-Tris (with MES running
buffer) precast mini-gels and a Novex Xcell II mini-cell apparatus.
Caspase-8 enzyme assay
Enzyme activity of caspase-8 preparations was monitored using the chro-
mogenic substrates Ac-DEVD-pNA or Ac-IETD-pNA (California Peptide
Research, Inc.). Kinetic release of pNA was followed spectrophotometri-
cally at 405 nm in reactions maintained at pH 7.5 and 37°C. 
Preparation of the caspase-8–inhibitor complex 
To a volume of 2.5 ml of a 8.4 mg/ml solution of caspase-8 (0.7 µmol) in
20 mM Tris, 100 mM DTT (pH 8.0) was added 140 µl of a 10 mM stock
solution of Ac-IETD-aldehyde in dimethyl sulfoxide (DMSO) (1.4 µmol,
twofold molar excess). The solution was stirred on ice for 30 min.
Crystallization and data collection
The caspase-8–Ac-IETD-thiohemiacetyl complex was crystallized by
hanging- and sitting-drop vapor diffusion [26]. Drops (3 µl) of
protein–inhibitor solution (8.4 mg/ml in 20 mM Tris, pH 8.0, 100 mM
DTT) were mixed with an equal volume of reservoir buffer (1.4 M
sodium citrate, 0.1 M HEPES, pH 8.0) and incubated at 4°C. The
average size of the crystals was 0.20 × 0.30 × 0.40 mm.
The crystals were mounted in nylon loops and frozen directly in a nitro-
gen stream just prior to measurement of the data. In the first data set,
X-ray diffraction data were measured using a rotating anode Cu Kα
source (50 kV, 100 mA) equipped with a Bruker Dual Hi-Star area
detector system. A 100% complete data set to 2.07 Å was used to
solve and refine the structure during the early rebuilding stages. The
second data set was measured at the Advanced Photon Source
(Argonne National Laboratory, Argonne, IL) IMCA-CAT beamline ID-17
using a wavelength of 1.03 Å and a Bruker Mosaic charged-couple
device (CCD) area detector system. Data collection and processing for
both crystals were carried out using SMART and SAINT software
[27,28]. The data collection statistics are given in Table 2.
Structure solution and refinement
The structure was solved by molecular replacement using the
program AMoRe in the CCP4 program suite [29,30] and the diffrac-
tion data (data set I) from the Bruker Dual Hi-Star system. A truncated
p10–p20 polyalanine search model based on the caspase-3 structure
(accession code 1CP3 in the Brookhaven Protein Data Bank [PDB])
[14] was used. A peak was found in the cross-rotation function with
the rotation angles α = 8.18, β = 62.21 and γ = 150.08 (peak
height = 7σ), in the resolution range 8–4.0 Å with an integration
radius of 25 Å. The two-dimensional translation function, calculated
with the search model rotated according to the above angles in the
resolution 8–3 Å, yielded a solution for the translation a = 0.2479,
b = 0.5195 and c = 0.1947 (correlation coefficient (r) = 19.8%, 
R factor = 0.519). Initial refinement was carried out with data set I
and PROFFT [31]. The high-resolution refinement was carried out
using the synchrotron radiation data set II. The structure was refined
by alternating rounds of restrained least squares using SHELXL97
[32] and manual interventions on the graphic terminal (CHAIN [33]
and LORE [34]). The R factor converged at 0.143 for all data greater
than 4σF between 8 and 1.2 Å resolution. The inhibitor, 334 water
molecules and two dithiane-diol molecules were included in the final
model. Hydrogen parameters for the nonsolvent atoms were included
in the model but not refined. Sulfur atoms were refined anisotropically.
The root mean square deviations for bond lengths and angles are
0.014 Å and 1.8°, respectively. Not all of the residues could be
assigned because the electron density was too weak. Five residues
were modeled with discrete alternate sidegroup configurations. In the
p18 and p11 dimers, 12 and five N-terminal residues, respectively,
could not be located due to disorder. Final refinement and
PROCHECK [35] statistics are included in Table 3. 
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Table 2
Summary of data collection and processing statistics.
Data set I II
Data collection method Dual Hi-Star Synchrotron
Resolution (Å) 40–2.07 40–1.20
Wavelength (Å) 1.54178 1.03321
Total reflections 107,109 298,890
Unique reflections 29,882 79,843
I/σ(I) (last shell) 5.49 (2.14–2.07) 2.35 (1.24–1.20)
Rmerge (F2)* 0.051 0.068
Redundancy 3.80 3.73
Completeness (%) 100 87
Temperature (K) 100 105




*Rmerge = Σhkl Σi \Fi2(hkl)–〈F 2(hkl)〉|/ΣhklΣiFi2(hkl).
Table 3
Refinement statistics for data set II. 
Resolution range (Å) 8.0–1.20
R factor (Fo > 4σ) 0.143
R factor (all reflections within range) 0.166
Rfree (Fo > 4σ) 0.165
Total reflections 75,433
Total reflections (Fo > 4σ) 60,671
Number of protein atoms (including alternate sites) 1945
Number of substrate atoms 51
Number of solvent atoms 334
Average B values (Å2)
mainchain 7.83
sidechain 14.18
solvent (full occupancy) 29.67
Stereochemistry
Bond distances
mainchain atoms/overall (Å) 0.014/0.017
Bond angles
mainchain atoms/overall (°) 1.8/1.8
Phi–Psi torsion angles
most favored regions (%) 89.0
Phi–Psi torsion angles
additional allowed regions (%) 11.0
Phi–Psi torsion angles
generous or disallowed (%) 0.0
Accession numbers
The atomic coordinates (accession code 1QTN) and structure
factors have been deposited in the RCSB Protein Data Bank
(http://www.rcsb.org/pdb/) and are on hold for one year.
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